Investing.com - Financial Markets Worldwide

Eubiologics Co Ltd (206650)

KOSDAQ
Currency in KRW
12,820
-50(-0.39%)
Closed·
206650 Scorecard
Full Analysis
Suffers from weak gross profit margins
Earnings results expected tomorrow
206650 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
12,70012,900
52 wk Range
9,62018,800
Key Statistics
Edit
Bid/Ask
12,800.00 / 12,820.00
Prev. Close
12,870
Open
12,890
Day's Range
12,700-12,900
52 wk Range
9,620-18,800
Volume
66.04K
Average Volume (3m)
188.41K
1-Year Change
22.13%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
206650 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 3
Valuation implies a poor free cash flow yield
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Eubiologics Co Ltd Company Profile

EuBiologics Co., Ltd., a biopharmaceutical company, provides vaccines for epidemics in South Korea. It offers Euvichol Plus, an oral cholera prevention vaccine; and rCRM197, a diphtheria toxoid vaccine. The company also provides EcML, a vaccine for cell membrane, as well as offers COVID-19 diagnostic kits. In addition, it offers CMO services comprising of drug product production, cell bank production, drug product production, and drug substance production. Further, the company provides CRMO services, including production process development, formulation development, analyticals method development, and licensing and approval consulting service; and operates facilities that manufacture protein-based therapeutics and antibodies. Additionally, it offers contract testing services that include lot release, stability, raw material, and method validation testing services. EuBiologics Co., Ltd. was founded in 2010 and is headquartered in Seoul, South Korea.

Industry
Pharmaceuticals
Sector
Healthcare
0
Market
South Korea

Compare 206650 to Peers and Sector

Metrics to compare
206650
Peers
Sector
Relationship
P/E Ratio
0.0x−4.4x−0.5x
PEG Ratio
0.00−0.090.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x19.5x3.3x
Upside (Analyst Target)
0.0%25.0%43.5%
Fair Value Upside
Unlock1.7%6.9%Unlock

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-- / --
Revenue / Forecast
39.50B / --
EPS Revisions
a
a
Unlock
Last 90 days

206650 Income Statement

FAQ

What Stock Exchange Does Eubiologics Trade On?

Eubiologics is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Eubiologics?

The stock symbol for Eubiologics is "206650."

What Is the Eubiologics Market Cap?

As of today, Eubiologics market cap is 471.35B.

What Is Eubiologics's Earnings Per Share (TTM)?

The Eubiologics EPS (TTM) is -380.79.

When Is the Next Eubiologics Earnings Date?

Eubiologics will release its next earnings report on 07 Aug 2025.

From a Technical Analysis Perspective, Is 206650 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Eubiologics Stock Split?

Eubiologics has split 1 times.

How Many Employees Does Eubiologics Have?

Eubiologics has 0 employees.

What is the current trading status of Eubiologics (206650)?

As of 07 Aug 2025, Eubiologics (206650) is trading at a price of 12,820.00, with a previous close of 12,870.00. The stock has fluctuated within a day range of 12,700.00 to 12,900.00, while its 52-week range spans from 9,620.00 to 18,800.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.